Management of Severe Hyponatremia (Sodium 112 mEq/L)
For severe hyponatremia (sodium 112 mEq/L), stop diuretics immediately and administer volume expansion with colloid or saline, while carefully limiting sodium correction to no more than 8 mEq/L in 24 hours to prevent osmotic demyelination syndrome. 1, 2
Initial Assessment and Classification
Hyponatremia with sodium of 112 mEq/L is classified as severe hyponatremia (<120 mEq/L) requiring prompt intervention. The management approach depends on:
Volume status assessment:
- Hypovolemic: Signs of dehydration, orthostatic hypotension
- Euvolemic: No signs of volume depletion or overload
- Hypervolemic: Edema, ascites, signs of heart failure
Presence of neurological symptoms:
- Mild: Nausea, headache, confusion
- Severe: Seizures, decreased consciousness, coma
Treatment Algorithm Based on Volume Status
For Hypovolemic Hyponatremia:
- Stop diuretics immediately 1
- Volume expansion with isotonic (0.9%) saline 2, 3
- For patients with elevated creatinine (>150 mmol/L), use colloid solutions (albumin, gelofusine, haemaccel) 1
- Monitor serum sodium every 4-6 hours during active correction 2
For Euvolemic Hyponatremia:
- Stop diuretics immediately 1
- Volume expansion with 3% hypertonic saline for severe symptoms 2, 3
- Initial bolus: 2 mL/kg
- Target correction: 4-6 mEq/L in first hour for severe symptoms
- Consider vasopressin receptor antagonists (tolvaptan) for persistent hyponatremia 2, 4
- Must be initiated in hospital setting
- Starting dose: 15 mg once daily
- May increase to 30 mg after 24 hours if needed
For Hypervolemic Hyponatremia:
- Stop diuretics immediately 1
- Volume expansion with colloid solutions despite worsening fluid retention 1
- Treat underlying cause (heart failure, cirrhosis) 2, 3
Critical Correction Rate Guidelines
- Maximum correction rate: 8 mEq/L in 24 hours 2
- Avoid correction >12 mEq/L in 24 hours to prevent osmotic demyelination syndrome 1, 4, 3
- Higher risk patients (alcoholism, malnutrition, liver disease) may require even slower correction rates 2, 4
Monitoring Requirements
- Check serum sodium every 4-6 hours during active correction 2
- Monitor for signs of fluid overload in hypervolemic patients
- Assess neurological status regularly
- Monitor renal function and other electrolytes
Special Considerations
Tolvaptan (vasopressin antagonist) must be initiated in hospital with close monitoring 4
High-risk patients for osmotic demyelination:
- Alcoholism
- Malnutrition
- Advanced liver disease
- Severe metabolic disorders
Post-Correction Management
- After initial correction, address underlying cause
- Resume fluid restriction after stabilization
- Monitor for rebound hyponatremia after treatment
- For patients with chronic hyponatremia, consider long-term management strategies based on underlying etiology
Common Pitfalls to Avoid
- Overly rapid correction leading to osmotic demyelination syndrome
- Water restriction alone in severe symptomatic hyponatremia
- Continuing diuretics in patients with sodium <120 mEq/L
- Failure to monitor serum sodium frequently during correction
- Underestimating risk in patients with alcoholism, malnutrition, or liver disease
Remember that the most critical aspect of managing severe hyponatremia is the careful control of correction rate to prevent neurological complications while addressing the underlying cause.